In this latest editor's desk, Reece Armstrong looks at the importance for pharma when collaborating with the tech industry.
Collaborations across the pharmaceutical industry are nothing new. Regularly, we see companies, big and small team-up so that knowledge, portfolios and intellectual property can be shared. Think of the start-up being acquired by the pharma giant because of its promising therapeutic. Or the biotech with an artificial intelligence (AI) algorithm that can sift through data in the search of promising candidate medications.
Pharmaceutical companies are always on the search for new talent. The intensive time and costs associated with drug discovery and development often mean it’s easier, or at least from a business perspective, less risky, to invest in promising companies that bring with them a wealth of knowledge or a therapy with encouraging data behind it.